Therapy Areas: Vaccines
17 November 2017 - - Ontario, Canada-based immuno-oncology company Turnstone Biologics has selected Mike Burgess, MBChB, Ph.D. for president of research and development, the company said.
Burge...
16 November 2017 - - Cambridge, Massachusetts-based messenger RNA therapeutics and vaccines developer Moderna Therapeutics has begun dosing patients in a Phase 1 study of mRNA-4157, an mRNA-based pers...
15 November 2017 - - US-based immuno-oncology company TapImmune Inc. (NASDAQ: TPIV) has completed patient enrollment in a randomized Phase 2 clinical study of its novel T-cell vaccine candidate TPIV20...
15 November 2017 - - US-based cancer-focused biotechnology company ITUS Corp. (NASDAQ: ITUS) has executed an exclusive worldwide license agreement with The Wistar Institute for a Chimeric Antigen Rece...
14 November 2017 - Animal health company AgriLabs reported on Monday the receipt of conditional approval from the USDA for the first DNA vaccine ever licensed for chickens.In conjunction, the company&...
13 November 2017 - - The global sexually transmitted diseases drug market was valued at USD 32,826.3m in 2016 and is projected to expand at a CAGR of 11.2% from 2017 to 2025 to reach USD 83,...